International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 3 , Pages 740-746 , 1 July 2009

Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography Before and After Definitive Radiation Therapy in Patients With Apparently Solitary Plasmacytoma

  • Paul J. Kim, M.D.

      Affiliations

    • Department of Radiation Oncology, California Pacific Medical Center, San Francisco, CA
    • ,
  • Rodney J. Hicks, M.D., FRACP.

      Affiliations

    • Centre for Molecular Imaging and Translational Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
    • ,
  • Andrew Wirth, FRACP, FRANZCR.

      Affiliations

    • Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
    • ,
  • Gail Ryan, FRANZCR.

      Affiliations

    • Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
    • ,
  • John F. Seymour, MB, BS, PhD, FRACP.

      Affiliations

    • Department of Haematology/Medical Oncology, Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, Victoria, Australia
    • ,
  • H. Miles Prince, M.D., FRACP.

      Affiliations

    • Department of Haematology/Medical Oncology, Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, Victoria, Australia
    • ,
  • Michael P. Mac Manus, M.D., FRANZCR.

      Affiliations

    • Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
    • Corresponding Author InformationReprint requests to: Michael P. Mac Manus, M.D., FRANZCR, Department of Radiation Oncology, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria 3002, Australia. Tel: (+613) 9656-1111; Fax: (+613) 9656-1424

Received 17 June 2008 ,Revised 21 August 2008 ,Accepted 21 August 2008.

References 

  1. Hernandez JA, Land KJ, McKenna RW. Leukemias, myeloma, and other lymphoreticular neoplasms. Cancer. 1995;75:381–394
  2. Knowling MA, Harwood AR, Bergsagel DE. Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol. 1983;1:255–262
  3. Dispenzieri A, Gertz MA. Treatment options for POEMS syndrome. Expert Opin Pharmacother. 2005;6:945–953
  4. Dispenzieri A. POEMS syndrome. Blood Rev. 2007;21:285–299
  5. Dimopoulos MA, Moulopoulos LA, Maniatis A, et al. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood. 2000;96:2037–2044
  6. Wilder RB, Ha CS, Cox JD, et al. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone. Cancer. 2002;94:1532–1537
  7. Bolek TW, Marcus RB, Mendenhall NP. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys. 1996;36:329–333
  8. Frassica DA, Frassica FJ, Schray MF, et al. Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 1989;16:43–48
  9. Holland J, Trenkner DA, Wasserman TH, et al. Plasmacytoma. Treatment results and conversion to myeloma. Cancer. 1992;69:1513–1517
  10. Jyothirmayi R, Gangadharan VP, Nair MK, et al. Radiotherapy in the treatment of solitary plasmacytoma. Br J Radiol. 1997;70:511–516
  11. Liebross RH, Ha CS, Cox JD, et al. Solitary bone plasmacytoma: Outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys. 1998;41:1063–1067
  12. Shih LY, Dunn P, Leung WM, et al. Localised plasmacytomas in Taiwan: Comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone. Br J Cancer. 1995;71:128–133
  13. Tsang RW, Gospodarowicz MK, Pintilie M, et al. Solitary plasmacytoma treated with radiotherapy: Impact of tumor size on outcome. Int J Radiat Oncol Biol Phys. 2001;50:113–120
  14. Liebross RH, Ha CS, Cox JD, et al. Clinical course of solitary extramedullary plasmacytoma. Radiother Oncol. 1999;52:245–249
  15. Dimopoulos MA, Goldstein J, Fuller L, et al. Curability of solitary bone plasmacytoma. J Clin Oncol. 1992;10:587–590
  16. Alexiou C, Kau RJ, Dietzfelbinger H, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer. 1999;85:2305–2314
  17. Strojan P, Soba E, Lamovec J, et al. Extramedullary plasmacytoma: clinical and histopathologic study. Int J Radiat Oncol Biol Phys. 2002;53:692–701
  18. Mayr NA, Wen BC, Hussey DH, et al. The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol. 1990;17:293–303
  19. Bataille R, Sany J. Solitary myeloma: Clinical and prognostic features of a review of 114 cases. Cancer. 1981;48:845–851
  20. Mulligan ME. Imaging techniques used in the diagnosis, staging, and follow-up of patients with myeloma. Acta Radiol. 2005;46:716–724
  21. Mendenhall CM, Thar TL, Million RR. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys. 1980;6:1497–1501
  22. MacManus MP, Seymour JF, Hicks RJ. Overview of early response assessment in lymphoma with FDG-PET. Cancer Imaging. 2007;7:10–18
  23. Schirrmeister H, Bommer M, Buck AK, et al. Initial results in the assessment of multiple myeloma using 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2002;29:361–366
  24. Mileshkin L, Blum R, Seymour JF, et al. A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma. Eur J Haematol. 2004;72:32–37
  25. Schirrmeister H, Buck AK, Bergmann L, et al. Positron emission tomography (PET) for staging of solitary plasmacytoma. Cancer Biother Radiopharm. 2003;18:841–845
  26. Braams JW, Pruim J, Kole AC, et al. Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg. 1997;26:112–115
  27. Kato T, Tsukamoto E, Nishioka T, et al. Early detection of bone marrow involvement in extramedullary plasmacytoma by whole-body F-18 FDG positron emission tomography. Clin Nucl Med. 2000;25:870–873
  28. Kole AC, Nieweg OE, Pruim J, et al. Detection of unknown occult primary tumors using positron emission tomography. Cancer. 1998;82:1160–1166
  29. Orchard K, Barrington S, Buscombe J, et al. Fluoro-deoxyglucose positron emission tomography imaging for the detection of occult disease in multiple myeloma. Br J Haematol. 2002;117:133–135
  30. Karp JS, Muehllehner G, Mankof FD, et al. Continuous-slice PENN-PET: A positron tomograph with volume imaging capability. J Nucl Med. 1990;31:617–627
  31. Burger C, Goerres G, Schoenes S, et al. PET attenuation coefficients from CT images: Experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients. Eur J Nucl Med Mol Imaging. 2002;29:922–927
  32. Kalff V, Hicks RJ, MacManus MP, et al. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: A prospective study. J Clin Oncol. 2001;19:111–118

 Conflict of interest: none.

PII: S0360-3016(08)03396-8

doi: 10.1016/j.ijrobp.2008.08.037

International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 3 , Pages 740-746 , 1 July 2009

Article Tools

* Image Usage & Resolution